Literature DB >> 3422262

Memory function in disease-free survivors of childhood acute lymphocytic leukemia given CNS prophylaxis with or without 1,800 cGy cranial irradiation.

R K Mulhern1, A L Wasserman, D Fairclough, J Ochs.   

Abstract

Previous studies have found that CNS prophylaxis of children with leukemia, especially young children receiving cranial irradiation, causes neuropsychologic deficits. In the present study, 40 children in continuous complete remission from acute lymphocytic leukemia (ALL) were given a battery of tests to assess memory functioning 5 years after CNS prophylaxis. All children were free of CNS disease at diagnosis and had been randomly assigned to receive CNS prophylaxis with either 1,800 cGy cranial irradiation (CRT) plus intrathecal (IT) methotrexate (MTX) or IT MTX plus intravenous (IV) high-dose MTX (HDMTX). No treatment- or age-related differences were seen on 16 standardized memory measures. However, scores of the combined sample were significantly lower than age-corrected norms on a test of visual-spatial memory and on four scales of verbal memory. Differences in methods or intensity of CNS prophylaxis and study group selection criteria are proposed to explain our findings and to resolve discrepancies with previous reports. The long-term neuropsychological sequelae in these survivors of ALL may be attributable to some common factor, such as the disease itself or systemic and IT chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422262     DOI: 10.1200/JCO.1988.6.2.315

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  14 in total

1.  [The late psychosocial sequelae in long-term survivors after acute lymphoblastic leukemia in childhood].

Authors:  D Wenzel; M A Uberall
Journal:  Strahlenther Onkol       Date:  1999-04       Impact factor: 3.621

2.  Mathematics intervention for prevention of neurocognitive deficits in childhood leukemia.

Authors:  Ida M Moore; Marilyn J Hockenberry; Cynthia Anhalt; Kathy McCarthy; Kevin R Krull
Journal:  Pediatr Blood Cancer       Date:  2011-09-21       Impact factor: 3.167

Review 3.  CNS prophylaxis of childhood leukemia: what are the long-term neurological, neuropsychological, and behavioral effects?

Authors:  J A Stehbens; T A Kaleita; R B Noll; W E MacLean; R T O'Brien; M J Waskerwitz; G D Hammond
Journal:  Neuropsychol Rev       Date:  1991-06       Impact factor: 7.444

Review 4.  Oncology.

Authors:  J S Malpas
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

5.  Decline in head growth and cognitive impairment in survivors of acute lymphoblastic leukaemia.

Authors:  R E Appleton; K Farrell; J Zaide; P Rogers
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

6.  Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.

Authors:  J M Chessells; T C Cox; B Kendall; N P Cavanagh; L Jannoun; S Richards
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

Review 7.  A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy.

Authors:  Carol L Armstrong; Kunsang Gyato; Abdel W Awadalla; Robert Lustig; Zelig A Tochner
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

8.  Intellectual, educational, and behavioural sequelae after cranial irradiation and chemotherapy.

Authors:  V Anderson; E Smibert; H Ekert; T Godber
Journal:  Arch Dis Child       Date:  1994-06       Impact factor: 3.791

9.  Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemia.

Authors:  W E Reddick; J O Glass; D P Johnson; F H Laningham; C-H Pui
Journal:  AJNR Am J Neuroradiol       Date:  2009-07-30       Impact factor: 3.825

Review 10.  Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia.

Authors:  Wilburn E Reddick; Fred H Laningham; John O Glass; Ching-Hon Pui
Journal:  Neuroradiology       Date:  2007-07-26       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.